I detail why it will likely beat the Nasdaq 100 in 2025.

is presenting today at the 43rd Annual J.P. Morgan Healthcare Conference. During the presentation, Chairman and CEO Michael B. Petras, Jr. will be providing an update on Sotera Health’s business.

Qualcomm (NASDAQ:QCOM) was in focus on Tuesday as J.P. Morgan placed the semiconductor company on a positive Catalyst Watch ...

today announced that it will participate in the J.P. Morgan 43rd Annual Healthcare Conference, January 12-16, 2025. BioUtah President and CEO, Kelvyn Cullimore, will attend on behalf of the ...

Fintel reports that on January 16, 2025, JP Morgan initiated coverage of Expand Energy (NasdaqGS:EXE) with a Overweight recommendation. Price T Rowe Associates holds 14,203K shares representing 6. ...

RESEARCH TRIANGLE PARK, N.C., Jan. 07, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the 43rd Annual J.P. Morgan ...

LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative ... will present at the 43rd Annual J.P. Morgan Healthcare Conference at 7:30 a.m. PT on Thursday ...

Janney Montgomery Scott LLC cut its stake in shares of iShares J.P. Morgan USD Emerging Markets Bond ETF (NASDAQ:EMB – Free Report) by 0.9% during the fourth quarter, according to the company in ...

I am pleased to announce that Sotera Health delivered another year of top-line growth in 2024,” said Mr. Petras. “We expect full-year revenues will be approximately $1.1 billion, representing growth ...

Ollie's Bargain Outlet Holdings (NASDAQ:OLLI) was one of the biggest gainers in the consumer sector on Thursday after J.P. Morgan added the stock to its Analyst Focus List on its view the retailer ...

Morgan Stanley analyst Michael Cyprys maintained a Buy rating on Nasdaq (NDAQ – Research Report) today and set a price target of $93.00. The company’s shares closed yesterday at $78.39.